162 related articles for article (PubMed ID: 11068141)
1. Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain.
Chan RK; Vale WW; Sawchenko PE
Neuroscience; 2000; 101(1):115-29. PubMed ID: 11068141
[TBL] [Abstract][Full Text] [Related]
2. Do centrally administered neuropeptides access cognate receptors?: an analysis in the central corticotropin-releasing factor system.
Bittencourt JC; Sawchenko PE
J Neurosci; 2000 Feb; 20(3):1142-56. PubMed ID: 10648719
[TBL] [Abstract][Full Text] [Related]
3. Involvement of serotonergic pathways in mediating the neuronal activity and genetic transcription of neuroendocrine corticotropin-releasing factor in the brain of systemically endotoxin-challenged rats.
Laflamme N; Feuvrier E; Richard D; Rivest S
Neuroscience; 1999 Jan; 88(1):223-40. PubMed ID: 10051203
[TBL] [Abstract][Full Text] [Related]
4. Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons.
Spiga F; Lightman SL; Shekhar A; Lowry CA
Neuroscience; 2006; 138(4):1265-76. PubMed ID: 16488545
[TBL] [Abstract][Full Text] [Related]
5. Urocortin expression in rat brain: evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors.
Bittencourt JC; Vaughan J; Arias C; Rissman RA; Vale WW; Sawchenko PE
J Comp Neurol; 1999 Dec; 415(3):285-312. PubMed ID: 10553117
[TBL] [Abstract][Full Text] [Related]
6. Effects of treadmill running on brain activation and the corticotropin-releasing hormone system.
Timofeeva E; Huang Q; Richard D
Neuroendocrinology; 2003 Jun; 77(6):388-405. PubMed ID: 12845225
[TBL] [Abstract][Full Text] [Related]
7. Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-alpha.
Hayley S; Staines W; Merali Z; Anisman H
Neuroscience; 2001; 106(1):137-48. PubMed ID: 11564424
[TBL] [Abstract][Full Text] [Related]
8. Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons.
Staub DR; Evans AK; Lowry CA
Brain Res; 2006 Jan; 1070(1):77-89. PubMed ID: 16403469
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing factor (CRF), but not corticosterone, increases basolateral amygdala CRF-binding protein.
Herringa RJ; Mackenrodt DB; Barlow JD; Roseboom PH; Nanda SA; Kalin NH
Brain Res; 2006 Apr; 1083(1):21-8. PubMed ID: 16545343
[TBL] [Abstract][Full Text] [Related]
10. Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions.
Pernar L; Curtis AL; Vale WW; Rivier JE; Valentino RJ
J Neurosci; 2004 Feb; 24(6):1305-11. PubMed ID: 14960601
[TBL] [Abstract][Full Text] [Related]
11. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain.
Morin SM; Ling N; Liu XJ; Kahl SD; Gehlert DR
Neuroscience; 1999; 92(1):281-91. PubMed ID: 10392850
[TBL] [Abstract][Full Text] [Related]
12. D-Fenfluramine induces serotonin-mediated Fos expression in corticotropin-releasing factor and oxytocin neurons of the hypothalamus, and serotonin-independent Fos expression in enkephalin and neurotensin neurons of the amygdala.
Javed A; Kamradt MC; Van de Kar LD; Gray TS
Neuroscience; 1999 Mar; 90(3):851-8. PubMed ID: 10218785
[TBL] [Abstract][Full Text] [Related]
13. Corticotropin-releasing hormone (CRH) downregulates the function of its receptor (CRF1) and induces CRF1 expression in hippocampal and cortical regions of the immature rat brain.
Brunson KL; Grigoriadis DE; Lorang MT; Baram TZ
Exp Neurol; 2002 Jul; 176(1):75-86. PubMed ID: 12093084
[TBL] [Abstract][Full Text] [Related]
14. Effect of blockade of corticotropin-releasing factor receptors in the median raphe nucleus on stress-induced c-fos mRNA in the rat brain.
Funk D; Li Z; Shaham Y; Lê AD
Neuroscience; 2003; 122(1):1-4. PubMed ID: 14596843
[TBL] [Abstract][Full Text] [Related]
15. Neuronal activity and stress differentially regulate hippocampal and hypothalamic corticotropin-releasing hormone expression in the immature rat.
Hatalski CG; Brunson KL; Tantayanubutr B; Chen Y; Baram TZ
Neuroscience; 2000; 101(3):571-80. PubMed ID: 11113306
[TBL] [Abstract][Full Text] [Related]
16. Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors.
Reyes TM; Lewis K; Perrin MH; Kunitake KS; Vaughan J; Arias CA; Hogenesch JB; Gulyas J; Rivier J; Vale WW; Sawchenko PE
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2843-8. PubMed ID: 11226328
[TBL] [Abstract][Full Text] [Related]
17. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system.
Liu S; Gao X; Gao N; Wang X; Fang X; Hu HZ; Wang GD; Xia Y; Wood JD
J Comp Neurol; 2005 Jan; 481(3):284-98. PubMed ID: 15593376
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.
Chen A; Vaughan J; Vale WW
Mol Endocrinol; 2003 Aug; 17(8):1622-39. PubMed ID: 12764078
[TBL] [Abstract][Full Text] [Related]
19. Injection of corticotropin-releasing hormone into the locus coeruleus or foot shock increases neuronal Fos expression.
Rassnick S; Hoffman GE; Rabin BS; Sved AF
Neuroscience; 1998 Jul; 85(1):259-68. PubMed ID: 9607717
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing hormone modulates airway vagal preganglionic neurons of Sprague-Dawley rats at multiple synaptic sites via activation of its type 1 receptors: Implications for stress-associated airway vagal excitation.
Guo Y; Yan X; Chen X; He D; Zeng M; Chen Y; Xia C; Qiu D; Wang J
Neuroscience; 2017 Jul; 355():101-112. PubMed ID: 28499969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
